Cargando…
Artificial chimeric exosomes for anti-phagocytosis and targeted cancer therapy
Development of exosome-based delivery systems is still facing some formidable challenges, including the lack of standardized isolation and purification methods, non-large-scale production and low drug-loading efficiency. Inspired by biomimetic technologies, we turned to the design of artificial chim...
Autores principales: | Zhang, Kai-Long, Wang, Ying-Jie, Sun, Jin, Zhou, Jie, Xing, Chao, Huang, Guoming, Li, Juan, Yang, Huanghao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357862/ https://www.ncbi.nlm.nih.gov/pubmed/30809374 http://dx.doi.org/10.1039/c8sc03224f |
Ejemplares similares
-
Chimeric antigen receptors that trigger phagocytosis
por: Morrissey, Meghan A, et al.
Publicado: (2018) -
Targeting mitochondrial degradation by chimeric autophagy-tethering compounds
por: Liu, Zhenqi, et al.
Publicado: (2023) -
Chimeric nanoparticles for targeting mitochondria in cancer cells
por: Bajpai, Aman, et al.
Publicado: (2022) -
Iron phosphide nanoparticles as a pH-responsive T(1) contrast agent for magnetic resonance tumor imaging
por: Qiu, Yuan, et al.
Publicado: (2019) -
Targeted Protein Degradation by Chimeric Small Molecules, PROTACs and SNIPERs
por: Naito, Mikihiko, et al.
Publicado: (2019)